Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro. (2022)

First Author: Castledine M
Attributed to:  Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.73679

PubMed Identifier: 35188102

Publication URI: http://europepmc.org/abstract/MED/35188102

Type: Journal Article/Review

Volume: 11

Parent Publication: eLife

ISSN: 2050-084X